TPX2 and neoplasm: Together, our results demonstrate the strong correlation between TPX2 expression and both molecular and clinical metrics of aggressive disease and poor clinical outcome, while also arguing that TPX2 IHC is not an appropriate standalone assay for the determination of CIN in human tumor samples.